Journey Medical Depreciation & Amortization Growth & History (DERM)

Journey Medical's depreciation and amortization was $4.3M for fiscal 2025.

View full Journey Medical company overview

Journey Medical annual depreciation and amortization history

Journey Medical annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$4.3M$831,000+23.64%
20242024-12-31$3.5M−$340,000−8.82%
20232023-12-31$3.9M−$510,000−11.68%
20222022-12-31$4.4M$4.4M
20212021-12-31$0−$5,000
20202020-12-31$5,000

Journey Medical depreciation and amortization trends

Over the last five fiscal years, Journey Medical's depreciation and amortization increased from $5,000 to $4.3M, a change of $4.3M. The latest reported quarter, Q2 2026, shows $992,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Journey Medical source filings ↗

Community posts

It’s quiet here.

No posts about DERM yet. Start the conversation.

Write the first post